Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...

Forbes contributors publish independent expert analyses and insights. As the CEO of Command Education, I write about emotionally intelligent leadership and education. This voice experience is ...

JPMorgan upgraded Recursion Pharmaceuticals (RXRX) to Overweight from Neutral with a price target of $11, up from $10. The firm says the company’s REC-4881 has shown “strong and durable” efficacy in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

China has been consolidating an ambition to build a world-class pharmaceutical industry. With the emergence of new technologies, collaboration paradigms, and institutional support, the next natural ...

Different share classes affect investment benefits, such as voting rights and dividend priorities. Mutual funds share classes vary by when and how load fees are charged and can affect long-term costs.

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.